Enveric Biosciences, Inc.

ENVB
$1.45 (- $0.03 - 2.03%)
Last updated: 2026-07-07 21:44 UTC
ENVB Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS29405E1091
CUSIP29405E109
Market Price1.45
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio0.0
EPS1390.68
Market Cap$4.8M
Book Value6.67
Price to Book0.703
Beta0.27
52w High1444.5
52w Low4.55
Next Earnings DateN/A

Enveric Biosciences, Inc. trades under ticker ENVB on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US29405E1091, CUSIP 29405E109.

About the Company
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.
Price History